As of 10:38am ET
| +0.12 / +3.07%|
The 6 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 15.00, with a high estimate of 40.00 and a low estimate of 9.00. The median estimate represents a +272.21% increase from the last price of 4.03.
The current consensus among 6 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.